Skip to main content

Year: 2023

Life Science Analytics Market Size to Surpass USD 37.20 Billion by 2030, at a CAGR of 13.6%

As per the report by Fortune Business Insights, The global life science analytics market size was valued at USD USD 12.81 billion in 2022. The industry is expected to expand from USD 15.27 billion in 2023 to USD 37.20 billion by 2030, exhibiting a CAGR of 13.6% over the study period.Life Science Analytics MarketForecast 2023-2030Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — Global life science analytics market size was valued at USD USD 12.81 billion in 2022. The industry is expected to expand from USD 37.20 billion by 2030 exhibiting a CAGR of 13.6% . Growing Use of Analytical Solutions for a Flexible and Comprehensive Research Study to Foster Market Growth The life science analytics market is inclusive of solutions, software, or analytical applications that are mostly deployed for the research and development of new...

Continue reading

VEON 3Q23 trading update: raising full-year revenue and EBITDA guidance, return to USD revenue growth, exit from Russia completed

New York, 20 November 2023 6:00AM ET – VEON Q3 2023 HighlightsRevenue of USD 945 million, +6.1% YoY (+19.3% YoY in local currency) Service revenue of USD 913 million, +6.9% YoY (+19.8% YoY in local currency) EBITDA of USD 444 million, +17.0% YoY (+30.6% YoY in local currency) Capex of USD 131 million, -29.8% YoY, with LTM capex intensity of 17.8% Revenues generated by 4G and Multiplay users of USD 474 million, +15.4% YoY (+27.7% YoY in local currency) Total cash and cash equivalents of USD 2.2 billion, with USD 1.8 billion at HQ Gross debt at USD 4.3 billion (decreased by USD 7.1 billion YoY), with net debt excluding lease liabilities at USD 1.3 billion (decreased by USD 3.9 billion YoY) Net debt to EBITDA excluding leases is 0.86x in the current quarter, a reduction from 3.3x from the third quarter of 2022 92 million 4G users, up 12.9%...

Continue reading

Prenetics Announces Third Quarter 2023 Financial Results

HONG KONG, Nov. 20, 2023 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced financial results for the third quarter ended September 30, 2023, along with recent business updates. Third Quarter 2023 Financial HighlightsRevenue from continuing operations of US$4.9 million Adjusted EBITDA from continuing operations of US$(6.4) million Cash and other short-term assets1 of US$105.2 million as of September 30, 2023; with an additional $79.1 million of cash with Insighta, our 50/50 joint venture in early cancer detection with Professor Dennis Lo“During the third quarter, we made further progress on our transformation. The recent completion of the reverse stock split also addressed any uncertainty regarding our listing status....

Continue reading

Probe Gold Commences Drilling Program on its Croinor Gold Property, Val-d’Or, Quebec

Figure 1Probe Gold Val-d’Or properties with the Croinor drilling areaHighlights:A 4,000-metre resource expansion drilling program is now underway on the recently acquired Croinor Gold property; Croinor is an underexplored, district-scale land package covering 152 square kilometres with significant resource expansion and exploration potential. It is close to the Novador development project and has the potential to contribute to its central mill design; The property hosts a current, high-grade, measured and indicated gold resource of 187,900 ounces of gold at 6.47 g/t and an inferred mineral resource of 39,800 ounces of gold at 6.19 g/t; Two drills have been mobilized and are focussed on extending and connecting the high-grade gold resources.TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) — PROBE GOLD INC. (TSX: PRB) (OTCQB:...

Continue reading

Kraken Announces Changes to Board of Directors

ST. JOHN’S, Newfoundland and Labrador, Nov. 20, 2023 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (“Kraken” or the “Company”) (TSX-V: PNG, OTCQB: KRKNF) is pleased to announce that effective November 20, Peter A. Hunter has been appointed to the Company’s Board of Directors. Mr. Hunter replaces Larry Puddister, a long time Kraken Director who has resigned. Mr. Puddister has other active business interests and has resigned from his board position with the Company to dedicate more attention to those interests.  Mr. Hunter is the founder, Chairman, and Managing Partner of Artemis Capital Partners, L.P., a Boston-based specialized private equity firm focused on differentiated industrial technology manufacturers. An attorney and a CPA, Mr. Hunter brings more than 30 years of experience as both an investor and operator. His areas of...

Continue reading

Hut 8 drives innovative recycling initiative for the second year running, earning 44% more carbon credits than in 2022

Partnering with Sparta Group’s ERS International, Hut 8 recycled retired miners and parts, earning 7,500 high-quality carbon credits Toronto, Nov. 20, 2023 (GLOBE NEWSWIRE) — Hut 8 Mining Corp. (Nasdaq | TSX: HUT) (“Hut 8” or “the Company”), one of North America’s largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure providers, partnered with Sparta Group’s carbon credit program established by their e-waste division, ERS International, with a goal of achieving carbon neutrality by 2025. In 2023, Hut 8 has submitted approximately 369 metric tonnes of electronic waste to the program, earning 7,500 metric tonnes carbon dioxide equivalent of serialized carbon credits. Under the recycling program, the first of its kind in Canada, after accounting for shipping and processing costs, for...

Continue reading

Hut 8 drives innovative recycling initiative for the second year running, earning 44% more carbon credits than in 2022

Partnering with Sparta Group’s ERS International, Hut 8 recycled retired miners and parts, earning 7,500 high-quality carbon credits TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) — Hut 8 Mining Corp. (Nasdaq | TSX: HUT) (“Hut 8” or “the Company”), one of North America’s largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure providers, partnered with Sparta Group’s carbon credit program established by their e-waste division, ERS International, with a goal of achieving carbon neutrality by 2025. In 2023, Hut 8 has submitted approximately 369 metric tonnes of electronic waste to the program, earning 7,500 metric tonnes carbon dioxide equivalent of serialized carbon credits. Under the recycling program, the first of its kind in Canada, after accounting for shipping and processing costs, for...

Continue reading

Immunology Market Size to Surpass USD 194.28 Billion by 2030, at a CAGR of 10.3%

As per the report by Fortune Business Insights, the global Immunology Market size is projected to reach USD 194.28 billion in 2030, at a CAGR of 10.3% during the forecast period, 2023-2030Immunology MarketForecast 2023-2030Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — Global Immunology Market Size was valued at USD 102.41 billion in 2022 and is projected to grow from USD 194.28 billion by 2030 exhibiting a CAGR of 10.3% during the forecast period. Immunology drugs strengthen the immune system to fight infections or to treat diseases such as arthritis and diabetes. The surge in cases of immunological disorders associated with environmental effects is a significant catalyst for the market’s expansion in immunological drugs and therapies. This information is provided by Fortune Business Insights™ in its research...

Continue reading

Spirometer Market Size to Surpass USD 891.5 Million by 2030, exhibiting a CAGR of 5.5%

As per the report by Fortune Business Insights, the global spirometer market size is projected to reach USD 891.5 million in 2030, at a CAGR of 5.5% during the forecast period, 2023-2030Spirometer MarketSpirometer Market Forecast (2030-2030)Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global spirometer market size is expected to expand from USD 613.3 million in 2023 to USD 891.5 million by 2030, exhibiting a CAGR of 5.5% over the study period. A spirometer is deployed for the diagnosis of chronic obstructive pulmonary disease (COPD), asthma, and other conditions that impact breathing. Fortune Business Insights™ provides this information in its research report, titled “Spirometer Market, 2023-2030”.Request a Free Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spirometers-market-100486Key...

Continue reading

Antiepileptic Drugs Market Size to Surpass USD 22.37 billion by 2030, exhibiting a CAGR of 4.4%

As per the report by Fortune Business Insights, the global Antiepileptic Drugs Market size is projected to reach USD 22.37 billion in 2030, at a CAGR of 4.4% during the forecast period, 2023-2030Antiepileptic Drugs (AED) MarketAntiepileptic Drugs (AED) Market Forecast (2023-2030)Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The antiepileptic drugs market size is anticipated to surge from USD 16.50 billion in 2023 to USD 22.37 billion by 2030, exhibiting a CAGR of 4.4% over the study period. The market growth is being driven by the high rate of disease prevalence and the escalating demand for various treatments. Fortune Business Insights™ provides this information in its research report, titled “Antiepileptic Drugs (AED) Market, 2023-2030”.Request a Free Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antiepileptic-drug-market-101189Key...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.